Skip to main content

FIIs pare stake in 30 stocks with m-cap of over Rs 50,000 crore; time to turn cautious?

 The 31 companies where FIIs have pared their holdings include Infosys, HDFC, ICICI Bank, ITC, Bharti Airtel, Bajaj Finserv, Titan Company, Eicher Motors and Tata Steel.

Foreign institutional investors (FIIs) pared stake sequentially in some of the prominent large-cap companies in the June quarter, data from AceEquity showed

From the universe of companies having a market capitalisation of more than Rs 50,000 crore, there are as many as 31 names in which FIIs pared their holdings. These include Infosys, HDFC, ICICI Bank, ITC, Bharti Airtel, Bajaj Finserv, Titan Company, Eicher Motors and Tata Steel.

Out of 31 companies, 19 have been trading lower so far in 2020. These include SBI, Coal India, ITC, Tata Steel, Tech Mahindra and IOC.

The rest 11 companies have given positive returns in 2020 so far, including Divi’s Laboratories, Dr. Reddy’s Laboratories, Infosys, Britannia, and HCL Technologies.



Does that mean that investors should turn cautious?

Well, experts are of the view that if we look at the data, FIIs have reduced the stake marginally which could be attributed to the rebalancing of portfolio, or booking profits amid the rise in valuations. Hence, the paring of the stake should not be viewed negatively.

“In most of the large-cap names where FIIs have reduced exposure the percentage reduction is very miniscule. This could be due to the continued selling and rotation seen in April even after the March month selling,” Rusmik Oza, Executive Vice President, Head of Fundamental Research at Kotak Securities told Moneycontrol.

“One cannot infer or draw any conclusion that these companies' growth model has become weak because of the minor reduction in FII holding. At times we see a rotation of flows within the large-cap space and last three months have been exceptional due to the pandemic crisis,” he said.

Oza further added that some of the minor reduction in exposure can get corrected in the September quarter as many of the laggards and underperforming large caps have rebounded sharply in July and August.

Other factors to track:

Tracking what Foreign institutional investors are doing is a good thing, but that should not be the only basis of making a buy or sell decision, suggest experts.

Investors should ideally see a trend for 3-4 quarters rather than basing their decision on statistics of one quarter, they say. There may be many factors why FIIs decided to reduce stake; hence, investors should do their own research before pressing buy or a sell button.

“There are many NIFTY-50 heavyweights where we have witnessed reduced exposure of FIIs but growth might play a vital role in the future and might drive benchmark indices. In my opinion, investors should wait at least 2-3 quarters before making any decision and question on a growth model,” Gaurav Garg, Head of Research at CapitalVia Global Research Limited told Moneycontrol.

“Investors should look for a good business driven by a good set of people who will always deliver good returns in the longer run. Corporate governance plays an important role when it comes to the sustainability of the business. Higher potential in earnings growth is always a good sign to invest in stock and hold for the long run,” he said.

Ajit Mishra, VP Research, Religare Broking told Moneycontrol that apart from FII holding, investors must look at various other factors such as its fundamental track record, financial leverage, and return ratios (particularly debt to equity).

“Further, it has also become very important to check on whether the company is facing any corporate governance issues as this leads to sharp valuation correction. Also, buying/selling would depend on what valuations the investor is interested in the stock and whether it is justified,” he said.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com/SD Solutions advises users to check with certified experts before taking any investment decisions.

Comments

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...